Innovative therapies in the treatment of keloids and hypertrophic scars. - Wikidata - wikimedia - TriplyDB

Innovative therapies in the treatment of keloids and hypertrophic scars.

Innovative therapies in the treatment of keloids and hypertrophic scars.

http://www.wikidata.org/entity/Q41813563

about

Emerging Therapies for Scar Prevention Management of keloids and hypertrophic scars: current and emerging options.The effect of p38MAPK on cyclic stretch in human facial hypertrophic scar fibroblast differentiation.Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on the Maxillofacial Area and Neck: A Meta-Analysis of Randomized Controlled Trials.Recent developments in the use of intralesional injections keloid treatment.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Current Therapeutic Approach to Hypertrophic Scars.Extensive Donor Site Keloids in Follicular Unit Extraction Hair Transplantation.Reduction of adhesion formation after knee surgery in a rat model by botulinum toxin A.Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model.Homeobox B9 facilitates hypertrophic scar formation via activating the mitogen-activated protein kinase signaling pathway.Wound Modulation with Botulinum Toxin Update on Keloid Management: Clinical and Basic Science Advances.Botulinum Toxin in the Field of Dermatology: Novel Indications.Chinese expert consensus on clinical prevention and treatment of scar

P2860

Q26778777-C843F196-BC11-49DC-A8BA-580DFDB09E32 Q34699606-35F5D42E-8F33-4DBE-AFE6-AD3F8332725F Q35018345-70CC5789-FDFB-4B8E-9441-CB13855D51DA Q35960364-F87089E9-9E39-4804-BE5D-1B01E106A883 Q38268118-58450EC6-376B-470E-929F-8355184DD234 Q38649653-DEEFD153-911C-4052-B64E-51C381A80385 Q39414298-71E0882D-AA15-45BC-B7E2-3D75E49E77DB Q41163974-8A3CF120-73B6-4906-9615-A3C908F68EDE Q41962174-D63F04ED-A992-441A-80FC-F4778EC094F5 Q42007158-54CD16F2-AA67-4907-8828-7DAA72424C11 Q42347167-89E85524-F4D1-4485-A4E9-E60B27B90532 Q42510822-93DD732E-0D87-474B-89C7-358FFF216318 Q42870701-00344F4D-DD27-402C-9B6C-EA51E1121CA1 Q47095114-F7E9786A-7D15-4B70-94AB-DEDA02CAA7B7 Q57922036-C793816C-5090-4A9D-8B5B-54DC2C359275

P2860

Innovative therapies in the treatment of keloids and hypertrophic scars.

http://www.wikidata.org/entity/Q41813563

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Innovative therapies in the treatment of keloids and hypertrophic scars.

@en

type

label

Innovative therapies in the treatment of keloids and hypertrophic scars.

@en

prefLabel

Innovative therapies in the treatment of keloids and hypertrophic scars.

@en

P1433

Q41813563-005EC769-CE79-4E84-8DC9-C3CC7334A7A2

P1476

Q41813563-C993F17D-9B5C-4862-8E0E-B3A4F1B35AD5

P2093

Q41813563-44472669-226F-4A09-BB55-63435FC4A9CA

Q41813563-9D1F88EA-F4E6-4B08-A9C3-993B87691A31

Q41813563-F6D2584E-9B8C-4207-A754-BF6B6778CDDB

Q41813563-F7075E40-5E5B-420D-9D72-F9AC99B041F1

P2860

Q41813563-0016E053-481E-4468-B46F-E3831298023B

Q41813563-05A076DC-5858-467F-BCDB-FB6A1B1D315E

Q41813563-081D2C03-274C-4A62-8052-E7F36435D053

Q41813563-0DFA9D9D-F16A-46E6-BDB4-85562E12B51B

Q41813563-11CCD587-AC73-4E32-B157-E526D3AD4793

Q41813563-12A768D4-FB8A-45CD-98DD-113C37A91D73

Q41813563-14B8CCBD-BC6A-4BC6-A56F-3C97A299A602

Q41813563-161B65FA-BDA8-43F2-A873-A37AC3B34E87

Q41813563-1D1A23B8-CF74-4995-BDF8-BB369971FDDA

Q41813563-1D39CCAC-0271-4A9C-BE44-EC18ECFB8C09

P304

Q41813563-DDE10AEE-B946-42AB-A152-4C1B3A0CD878

P31

Q41813563-4778090E-FCEF-43D1-8DDD-2574DC07DBCF

P433

Q41813563-4DCAAA6D-3DA4-43E4-805D-6AD94F45319F

P478

Q41813563-44EE5BEE-480B-45D2-97BD-4CD8AA975921

P577

Q41813563-27DE5E3E-FE90-496C-B776-9E62C3658B33

P698

Q41813563-7DEC26DA-D3EC-4942-BC1D-3163E8751160

P932

Q41813563-21A20DF7-95A8-413E-83B9-5A69C1D6ED27

P1433

The Journal of clinical and aesthetic dermatology

P1476

Innovative therapies in the treatment of keloids and hypertrophic scars.

@en

P2093

Brian Berman

http://www.w3.org/2001/XMLSchema#string

Martha H Viera

http://www.w3.org/2001/XMLSchema#string

Sadegh Amini

http://www.w3.org/2001/XMLSchema#string

Whitney Valins

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling

Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

Mechanism of activation of the TGF-beta receptor

Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen

The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells

How cells read TGF-beta signals

Novel opportunities in the treatment and prevention of scarring.

Application of mitomycin-C for head and neck keloids.

Do postsurgical interventions optimize ultimate scar cosmesis.

P304

20-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20725565

http://www.w3.org/2001/XMLSchema#string

P932

2922716

http://www.w3.org/2001/XMLSchema#string